Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

12
Number of overlapping holdings
25.0%
% of CANC's 48 holdings also in BBP
19.7%
% of BBP's 65 holdings also in CANC
Overlap by Weight
Sector Drift (CANC minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in CANC |
Weight in BBP |
Overlap | |
---|---|---|---|---|
BEIGENE LTD. SPONSORED ADR | 2.7% | 2.3% | 2.3% | |
ZAI LAB LTD. UNSPONSORED ADR | 3.0% | 2.2% | 2.2% | |
AMGEN INC | 2.8% | 2.0% | 2.0% | |
BRIDGEBIO PHARMA, INC. | 4.5% | 1.9% | 1.9% | |
EXELIXIS INC | 3.8% | 1.8% | 1.8% |
Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to BBP
REVOLUTION MEDICINES, INC. | 5.7% | |
ELI LILLY & CO | 5.4% | |
ROCHE HOLDINGS LTD-SPONS ADR | 5.1% | |
NOVARTIS AG | 4.3% | |
ASTRAZENECA PLC | 4.2% | |
BRISTOL-MYERS SQUIBB CO | 4.0% | |
NUVALENT, INC. CLASS A | 3.9% | |
SUMMIT THERAPEUTICS INC | 3.9% | |
GENMAB A/S SPONSORED ADR | 3.4% | |
MERUS N.V. | 3.2% |
CANC Underweight Relative to BBP
INTRA-CELLULAR THERAPIES INC | -2.6% | |
SAGE THERAPEUTICS INC | -2.2% | |
AXSOME THERAPEUTICS, INC. | -2.1% | |
SPRINGWORKS THERAPEUTICS, INC. | -2.1% | |
HALOZYME THERAPEUTICS INC | -2.1% | |
TG THERAPEUTICS INC | -2.1% | |
ASCENDIS PHARMA A/S | -1.8% | |
PTC THERAPEUTICS INC | -1.8% | |
DYNAVAX TECHNOLOGIES CORP | -1.8% | |
MADRIGAL PHARMACEUTICALS, INC. | -1.8% |